Sign up on here if you don't have your mobile handy
You are going to create a patient management account. This account is designed to give your patients access to CogniFit evaluations and training.
You are going to create a research account. This account is specially designed to help researchers with their studies in the cognitive areas.
You are going to create a student management account. This account is designed to give your students access to CogniFit evaluations and training.
You are going to create a family account. This account is designed to give your family members access to CogniFit evaluations and training.
You are going to create a company management account. This account is designed to give your employees access to CogniFit evaluations and training.
For personal use
I'm a health professional
For my family
I'm an educator
I'm a researcher
Employee Wellbeing
Developers
For users 16 years and older. Children under 16 can use CogniFit with a parent on one of the family platforms.
By clicking Sign Up or using CogniFit, you are indicating that you have read, understood, and agree to CogniFit's Terms & Conditions and Privacy Policy.
Carlos Rodríguez
Board Director
Carlos Rodriguez began his career at the Peugeot Group, before moving to the New Technologies department of Uralita, as Project Manager. Carlos has also worked for Procter & Gamble in Geneva in the marketing intelligence department. He was in charge of new product forecasting and the deployment of in-market sales tracking systems of major consumer brands. In addition, Carlos was responsible for managing cross-functional new products innovation. Carlos is a founding partner of the venture capital fund Milk Capital in Paris, where he was responsible for evaluating technology-based investments and the founder of Madrid Ventures, a tech accelerator for startups. Carlos is a member of the board of directors and CEO of CogniFit. He earned an Industrial Engineering Master Degree from the Polytechnic University Carlos III of Madrid, and the Grande Ecole INSA of Lyon, France.
Prof. Dr. Shlomo Breznitz
Professor of psychology and former president of the University of Haifa
Renowned cognitive psychologist, Professor Shlomo Breznitz has been engaged as visiting professor by numerous leading institutions including the University of California at Berkeley, Stanford University, London School of Economics, and the US Department of Health and Human Services' National Institutes of Health. Author of seven books and many scientific articles, Prof. Breznitz is founding director of the Center for the Study of Psychological Stress at the University of Haifa, where he also served as Lady Davis Professor of Psychology, Rector, and University President. He is currently one of the members of CogniFit's board of directors.
Nathanael Eisenberg
Entrepreneur & Investor
Mr. Eisenberg started his career in banking at Schroders in Geneva before working as a financial analyst in the Trading Room of the Union Bancaire Privé. Mr. Eisenberg then moved out of the banking industry and worked for the IT Consulting firm Cap Gemini in their Telecommunication group in London. He then transferred to Paris to assist in the management of a Publishing Group before being recruited in the European headquarters of Procter and Gamble in Geneva where he held marketing positions managing a portfolio of brands. Mr. Eisenberg then went with P&G to Madrid to oversee the launch of a key Home Care initiative in the Iberian market. After this commercial and marketing experience, Mr. Eisenberg went to Paris and founded with a group of partners Milk Capital, a Venture Capital fund specializing in micro to mid-sized investments in sectors ranging for telecommunication and internet technology. He then took over CogniFit as CEO and finally was elected Chairman in January 2014. Mr. Eisenberg is also the founder & CEO of Bayrock. Nathanael Eisenberg is graduated from the HEC Lausanne with a Master of Management and Business Administration.
Juan A. Beceiro Friedmann
Corporate Sales & Consulting
Mr. Friedmann spent 28 years in the healthcare (HC) industry, of which 14 years were with GEHC in a number of Sales and Marketing leadership positions in EU. Former CMO & BD Director for South EU (2007-2014). Prior roles: Marketing Director Diagnostics Imaging Drugs, Product Mgr. Cardiac Imaging at Amersham Health, Sales Manager at Life Technologies (LT, former Gibco-BRL company).Strong strategic foundation acquired through 3 decades of Sales, Marketing & BD roles at GEHC, Amersham and LT. He grew GEHC business by Alliances & new GTM plans,in particular GE’s MS by 13pts and won a public tender of $50m, increasing top line with +8%. Juan Antonio supported EU projects for key New Product Innovations, and x-industry partnerships to open up new sales channels for GE. And re-positioned several products to increase MS, too.Co-founded 37Celsius Capital Partners LLC, a digital health fund, is serving to grow TeleMedCare LLC, founded a Sport Clinic in Madrid and helped Boston Sci. new solutions in EU. He served on the EU Academic Innovation Programs, and in the Disease Initiatives EU Working Group at GE. Member of the Innovation Committee of IDIS (Spanish Private HC Association), and of the Innovation Committee of the Spanish Medtech Trade Association (Fenin). He received a Master degree in Marketing (ESIC), Master degree in Pharmaceutical Marketing & Management (EADA) and a Bachelor’s degree in Chemistry and Chemical Engineering (UAB) Barcelona. He received several Leadership & Executive training programs in GE and GE Healthcare.
Jon Kizner
Senior Vice President, Business Development at EVERSANA
Customer-focused Life Sciences Solutions Selling Executive with 20 years of over achievement in software applications and consulting services. Jon has helped dozens of Life Sciences innovators commercialize their assets from pre-launch (HEOR and value generation, pricing, market access and reimbursement, full branding and agency services) to launch (HUB services and integrated specialty pharma dispensation, 3PL) and in-market revenue maximization (sales teams, affordability and adherence programs, revenue management, process optimization). Before Eversana Jon had several sales and executive roles at Teranode, OpenText, and Model N.
Marc Filerman
Managing Partner, German Accelerator Life Sciences
Marc Filerman is Managing Partner at German Accelerator Life Sciences – an organization accelerating international growth of German startups. With over 30 years in healthtech, Marc has expertise in market development, commercialization, and innovation acceleration, and broad experience leading marketing, sales, and business development for large companies and startups. Marc co-founded a molecular imaging startup, and was Chief Commercial Officer at an NIH-funded hometech venture. Prior to that, Marc held multiple corporate leadership positions including VP of Global Marketing at iCAD, and Group Director of Marketing at Smith & Nephew. Marc holds MS and BS engineers degrees from MIT, did his graduate work at the MIT AI Lab, and started his career designing ultrasound imaging equipment.
Jordi Albo-Canals
Chief Scientific Officer at Lighthouse DIG
Jordi is a renowned expert in social agents, emotion artificial intelligence, cloud computing platforms, healthtech, and edtech with over 100 publications on international conferences, journals, and book chapters. He is now the co-founder and CSO of the LIGHTHOUSE – Disruptive Innovation Group. During this career Jordi was senior Research Scientist Sant Joan de Déu Innovation and R&D department– Barcelona Children’s Hospital Foundation, CSO of the Empowered Brain Institute, Affiliate Researcher at Tufts University, Affiliate Researcher at MIT Media Lab, CSO of the Boston Exponential Hub at NTT DATA CORP, Robotics Innovation and Scientific Manager at NextGen everis-NTT DATA. Jordi graduated as Telecommunications Engineering (EE/CS) from La Salle - Ramon Llull University, Barcelona (Spain)
Nnamdi Alozie
Healthcare Strategy | Innovation
Healthcare and management executive with over 15 years experience in strategy, operations, and Innovation. Committed to building a healthier, equitable and efficient healthcare system. Nnamdi is the Director of Corporate Strategy at Indiana University Health, Investor at What If Ventures and Board Member at The Coneflower Institute & Liberty Grove Schools.
Prof. Josep Brugada Terradellas
MD, PhD, FESC is a Cardiologist, Specialist in Biology and Sport Medicine and MBA Management in Health Services.
Prof Brugada is a Senior Consultant at the Hospital Clínic, Barcelona and Head of the Arrhythmia Section at the Pediatric Hospital Sant Joan de Déu and Head of the Arrhythmia Unit of the Clínica Quirón Palmaplanas and Clínica Rotger in Palma de Mallorca and Clínica Girona in Girona. Consultant in Clínica Teknon, Barcelona. Past President of the European Heart Rhythm Association. He has published more than 500 original papers in the most relevant international journals, with an H index of 83 and more than 25.000 citations. Prof. Brugada held also the post of Deputy Editor of the European Journal of Cardiology. He is member of several scientific societies and is Professor of Cardiology at the University of Barcelona since 1998. He discovered, treated and found the genetic cause of a rare syndrome causing Sudden Death, which is known in the scientific literature as “Brugada Syndrome”. He is Doctor Honoris Causa by several Universities around the world and he has received multiple Prices and Awards including the Fritz-Acker Award of the German Society of Cardiology, the Josep Trueta Award of the Catalan Academy of Medical Sciences, and the Rey Jaime I Award in clinical medicine.
Carlos Rodríguez
Chief Executive Officer
Carlos Rodriguez began his career at the Peugeot Group, before moving to the New Technologies department of Uralita, as Project Manager. Carlos has also worked for Procter & Gamble in Geneva in the marketing intelligence department. He was in charge of new product forecasting and the deployment of in-market sales tracking systems of major consumer brands. In addition, Carlos was responsible for managing cross-functional new products innovation. Carlos is a founding partner of the venture capital fund Milk Capital in Paris, where he was responsible for evaluating technology-based investments and the founder of Madrid Ventures, a tech accelerator for startups. Carlos is a member of the board of directors and CEO of CogniFit. He earned an Industrial Engineering Master Degree from the Polytechnic University Carlos III of Madrid, and the Grande Ecole INSA of Lyon, France.
Tommy Sagroun
Chief Financial Officer
Tommy Sagroun started his career in consulting and financial services in Paris, France. He spent several years at Deloitte where he worked in M&A and auditing for listed and non-listed companies. Leveraging his consulting and coding knowledge, he designed and developed an audit software that became part of Deloitte France methodology. Tommy left Paris to join the New York branch of Barclays where he was responsible for business development in the biotechnology and health tech industries. Tommy joined CogniFit as Chief Product Officer (CPO) in May 2010 and became Chief Executive Officer (CEO) in January 2014. He stepped down as CEO in April 2021 and remains active in the company as the Chief Financial Officer (CFO), overseeing strategic partnerships and all financial aspects of the company. Tommy began his education in medicine and later switched to business, earning a Doctorate in Finance, Tax, and Accounting from the Académie de Paris, France.
Prof. Dr. Shlomo Breznitz
Professor of psychology and former president of the University of Haifa
Prof. Dr. Rocío Fernández-Ballesteros
Universidad Autónoma de Madrid | UAM · Biological and Health Psychology
Prof. Josep Brugada Terradellas
MD, PhD, FESC is a Cardiologist, Specialist in Biology and Sport Medicine and MBA Management in Health Services.
Prof. Dr. Henri Cohen
University of Québec at Montréal | Editor in Chief of Brain and Cognition